MD, Stanford University
Agnieszka Czechowicz is an immigrant from Poland
Fellowship awarded to support work towards an MD in Medicine at Stanford University
AGNIESZKA CZECHOWICZ is an Assistant Professor at Stanford University. She is a pediatric hematologist/oncologist, and sub-focuses on pediatric stem cell transplantation. She also runs a translational research group focusing on understanding hematopoeitic stem cells and how they interact with their microenvironments.
Agnieszka, was born in Poland. She grew up in Minnesota, and her family now resides in California. All are naturalized citizens.
Agnieszka completed her residency in Pediatrics at Boston Children's Hospital, and pursued fellowship training at the Dana Farber Cancer Institute and Lucile Packard Children's Hospital. She graduated from Stanford University School of Medicine with a MD/PhD in developmental biology in the Medical Scientist Training Program, in record breaking time. She also earned an undergraduate degree with honors from Stanford University, in biological sciences and received the Firestone medal for her outstanding senior thesis.
Agnieszka is an author on numerous publications, including a first author on a paper published in the November 2007 issue of Science which shows a possible way to eliminate the toxicity of bone marrow transplantation (BMT), a discovery that could expand the applications of BMT to include cures for most blood diseases, as well as autoimmune diseases like diabetes. She is in the process of translating these discoveries and developing them into new therapies for patients.
Agnieszka has also been very active in her community. She served as a student government representative, on the board of trustees, and a mentor to many undergraduate students. She has been a clinical and public health intern in Honduras, a BioBridge Advisor, a volunteer for Little Children of the World in the Philippines, and visiting scholar at Memorial-Sloan Kettering Cancer Center. She addition she has also worked at Third Rock Ventures, a VC firm that multiple Soros fellows have worked at that works on launching extraordinary life sciences companies.